BPC-157
A synthetic peptide derived from a protein in human gastric juice — widely used in research-peptide markets for soft tissue healing and gut repair.
Why it matters
BPC-157 (Body Protection Compound) is a 15-amino-acid sequence derived from a stomach protective protein. Animal studies show accelerated healing of tendon, ligament, muscle, and intestinal mucosa, with proposed mechanisms involving angiogenesis, growth factor expression, and nitric oxide modulation. Human clinical data is limited.
In practice
Typical research-peptide use protocols call for daily subcutaneous injection at 200–500mcg for 2–6 weeks. Oral BPC-157 is marketed for gut applications; subcutaneous is the dominant injection route for soft-tissue targets.
Common confusion
BPC-157 is sometimes presented as an FDA-approved healing therapy. It is not approved for any human indication; the entire commercial market operates in a research-use-only grey zone.
This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.
